The Importance of Conformational Dynamics for Drug Discovery Exemplified with TNFα and AGP1 — an NMR Study

Abstract

Protein-ligand interactions lie at the heart of most biological and medical processes. To lay the groundwork for a mechanistic understanding of complex biological networks, a detailed description of the associated proteins, their roles, and their interaction partners is essential. Furthermore, a detailed description of protein-ligand interactions is of pharmaceutical interest, as small molecules targeting proteins constitute the basis for the treatment of numerous medical conditions. In this thesis, we used nuclear magnetic resonance (NMR) spectroscopy to probe the conformational properties of biologically and pharmaceutically essential proteins, either alone or complexed with small molecules, to reveal the mechanistic grounds of these interactions. The first chapter entails the structural investigation of Tumor necrosis factor-alpha (TNFα) by NMR spectroscopy. TNFα is a homotrimeric protein that enjoys tremendous scientific and pharmaceutical interest due to its pivotal role in the human immune response. However, its overexpression leads to numerous chronic inflammatory diseases. Studying the interaction between TNFα and small molecular inhibitors is thus of utmost importance if better cures for these diseases are to be found. Here, we investigated active and inhibited forms of TNFα in solution by NMR spectroscopy and showed that TNFα exhibits significant conformational exchange, especially in the receptor binding site and the trimer interface, which is crucial for its biological activity. Inhibition of TNFα by perturbing the trimer interface, either by mutagenesis or by targeting it with small molecules, does not lead to disruption of the postulated trimer in solution. Instead, it induces a significant increase in the conformational dynamics of TNFα propagating from the trimer interface to the receptor-binding site. Therefore, we propose that an allosteric dynamic coupling between the trimer interface and the active site mediates inhibition. This provides novel insights into the mechanisms of TNFα inhibition, which in turn may lead to the development of better-suited drug assays against this highly important molecule. The second chapter presents the study of alpha acid glycoprotein-1 (AGP1) by NMR. The heavily glycosylated AGP1 is one of the two most abundant human serum proteins and binds various metabolites as well as, perhaps most interestingly from a pharmaceutical perspective, many administered drugs. Understanding the interaction between AGP1 and small molecules on a molecular level in addition to revealing the yet unclear impact of the appended glycans in this process is thus of great importance - as drug binding to plasma proteins modulates their pharmacokinetics and pharmacodynamics. In this thesis, efficient protocols were developed which enabled us to shed light on the influence of glycosylation on the structure of AGP1 and to characterize its ligand binding at a level of detail which had not yet been achieved. We showed that glycosylation affects the protein conformation in the vicinity of the glycosylation site, and provide evidence for a conformational rearrangement upon binding of small molecules. By giving these novel insights, our results contribute to the functional understanding of AGP1 and more broadly to the relatively unexplored class of glycoproteins. The third chapter discusses the combination of our measured NMR data (presented in chapters one and two) with DNA-encoded chemical libraries (DECL) in drug discovery. DECL allows for the efficient identification of potential small molecule binders, while our concomitant NMR data provide the framework for assisting both the validation of ‘hits’ and the optimization process. We could confirm interactions between TNFα or AGP1 and binders identified by DECL. Here, the first application of this approach for drug discovery for TNFα and AGP1 is presented. In summary, our study contributes to a better understanding of two highly relevant proteins: AGP1 and TNFα. The data presented provides original insights into the inhibition mechanisms of small molecules and revealed the importance of conformational dynamics in these processes. Finally, our results will add a new aspect to the complex process of rational drug development, which will ultimately benefit many patients affected by diverse medical conditions.